Due to transition in the journal platform, the previously submitted articles, which are under process can be re-submitted here for quick process, kindly co-operate

Biomedicine

Volume: 41 Issue: 4

  • Open Access
  • Case Report

Fibromyxoid sarcoma of maxilla

Deviprasad Dosemane1, Cheryl Sarah Philipose2, Deepa Adiga3, Meera Niranjan Khadilkar4, Sanchit Bajpai5

1Professor & Head, 4Assistant Professor, 5Fellow in Head & Neck Oncology, Department of Otorhinolaryngology and Head & Neck Surgery, Kasturba Medical College, Mangalore, Manipal Academy of Higher Education, Manipal, 575001, Karnataka, India.
2, 3Associate Professor, Department of Pathology, Kasturba Medical College, Mangalore, Manipal Academy of Higher Education, Manipal, 575001, Karnataka, India

Corresponding author: Meera Niranjan Khadilkar. Email: [email protected]

Year: 2021, Page: 859-861, Doi: https://doi.org/10.51248/.v41i4.843

Abstract

A recurrent mass in the nose can pose diagnostic and therapeutic challenges. Even more so, if it exhibits rapid growth, displays unusual clinical features, is a rare histopathological diagnosis or if the patient is unavailable for regular follow-up. We present a case of a middle-aged retrovirus-positive man who underwent surgical removal of a recurrent nasal mass. Histopathology revealed a diagnosis of low-grade fibromyxoid sarcoma, a rare entity in the sinonasal tract. Immunohistochemistry plays a crucial role in clinching the diagnosis, especially for lesions with fibrous and myxoid components. Early and complete surgical resection diminishes the likelihood of recurrence and metastasis.

Keywords: Maxilla; immunohistochemistry; nasal neoplasms; sarcoma; sinonasal tract.

Cite this article

Deviprasad Dosemane, Cheryl Sarah Philipose, Deepa Adiga, Meera Niranjan Khadilkar, Sanchit Bajpai. Fibromyxoid sarcoma of maxilla. Biomedicine: 2021; 41(4): 859-861

Views
66
Downloads
18
Citations